Patents by Inventor Aviv Lutaty

Aviv Lutaty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11619634
    Abstract: A method of diagnosing lung cancer in a subject-in-need thereof is provided. The method comprises: (a) providing a biological sample of the subject which comprises peripheral blood mononuclear cells (PBMCs); (b) in vitro contacting the PBMCs with a stimulant selected from the group consisting of the stimulants listed in Tables 3 and 4; and (c) measuring metabolic activity of the PBMCs having been contacted according to (b), wherein a statistically significant change in the metabolic activity of the PBMCs as compared to a control sample is indicative of lung cancer.
    Type: Grant
    Filed: August 20, 2018
    Date of Patent: April 4, 2023
    Assignees: Savicell Diagnostic Ltd., Ramot at Tel-Aviv University Ltd.
    Inventors: Giora Davidovits, Fernando Patolsky, David Eyal Davidovits, Irit Arbel, Shoval Tirman, Aviv Lutaty, Tali Scienmann, Reuven Tirosh, Hagit Peretz-Soroka
  • Patent number: 9850278
    Abstract: The present invention is directed to synthetic anti-inflammatory peptides and use thereof in the treatment and prevention of inflammatory and fibrotic conditions. Specifically, the invention relates in some embodiments to short isolated peptides having the amino acid sequence Phe-Lys-Glu (FKE), Tyr-Lys-Glu (YKE) or comprising a plurality of these sequences that may be flanked by Ala/Gly (A/G) linkers. The invention further relates in some embodiments to methods for inhibiting scar formation and for treating and alleviating IL-10 dependent conditions.
    Type: Grant
    Filed: April 23, 2014
    Date of Patent: December 26, 2017
    Assignee: Carmel-Haifa University Economic Corp.
    Inventors: Amiram Ariel, Aviv Lutaty
  • Patent number: 9562893
    Abstract: Novel lactoferrin fragments that are characteristic of inflammation during resolution and uses thereof. Diagnostic compositions and methods for assessing the presence or absence of resolving inflammation and for monitoring the progression of inflammatory resolution in a subject. Methods for treating a subject having an inflammatory disease, the methods including determining whether the subject has inflammation in resolution by determining the molecular weight of lactoferrin fragments.
    Type: Grant
    Filed: January 24, 2014
    Date of Patent: February 7, 2017
    Assignee: CARMEL-HAIFA UNIVERSITY ECONOMIC CORP.
    Inventors: Amiram Ariel, Aviv Lutaty
  • Publication number: 20140162377
    Abstract: Novel lactoferrin fragments that are characteristic of inflammation during resolution and uses thereof. Diagnostic compositions and methods for assessing the presence or absence of resolving inflammation and for monitoring the progression of inflammatory resolution in a subject. Methods for treating a subject having an inflammatory disease, the methods including determining whether the subject has inflammation in resolution by determining the molecular weight of lactoferrin fragments.
    Type: Application
    Filed: January 24, 2014
    Publication date: June 12, 2014
    Applicant: CARMEL-HAIFA UNIVERSITY ECONOMIC CORP.
    Inventors: Amiram Ariel, Aviv Lutaty